A clinical study to assess chlorpromazine as hypoxic cell sensitizer in head & neck cancer treated with conventional radiation

Indian Journal of Cancer

Volumn 35, Issue 3, 1998, Pages 97-100

  Huilgol, Nagraj G ^a   Chatterjee, Neela ^a   Singh, B B ^b  

^a DR BALABHAI NANAVATI HOSPITAL   (India)

^b Radiat Biol Chem Bhabha A

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; RADIOSENSITIZING AGENT;

ARTICLE; CELL HYPOXIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HEAD AND NECK TUMOR; HUMAN; MORTALITY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; SURVIVAL; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CHLORPROMAZINE; HEAD AND NECK NEOPLASMS; HUMANS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032149464     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Abe Koji, Sezawa T. and Kongure K.: Biphasic effects of CPZ on cell viability in neuroblastoma cell line. Neurosciences Letters 1986:71;335-339.
2. Hatt W. N. and Lee G. L. : Characteristics of the cytotoxic effects of the phenothiazine class of calmodulin antagonists. Biochemical Pharmacology 1985 : Vol. 32, No. 22;3973-78.
3. Hirai H., Takeda S., Natori S., Sekimizu K.: Inhibition of SV40 DNA replication in vitro by chlorpromazine Biol. Pharm. Bull. : 1993 16(6); 565-7.
4. 2 Blocker effects of CPZ are crucial in understanding antiproliferative potential as well as protective. Molecular Pharmacology 1976:12: 581.
5. Nokano M., Sugioko K., Nakano H., Takay C. and Iraba H. : Generation of electrically excited species during enzymatic oxidation of CPZ and related compounds. Biochem. Biophys. Res. Commn. 1985:130;952-56.
6. Maniar and Singh B. B. Radiosensitzing and radioprotective effects of CPZ. Indian Journal of Experimental Biology 1985:23:100-2.
7. Martindale, the extra Pharmacopoeia Ed. 1989 The Pharmaceutical Press London, pp 706-722.